Get the Stockscreener App
1.48
0.68%
+0.01
After Hours:
1.48
DarioHealth Corp stock is currently priced at $1.48, with a 24-hour trading volume of 73,065.
It has seen a +0.68% increased in the last 24 hours and a -2.31% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.47 pivot point. If it approaches the $1.50 resistance level, significant changes may occur.
Previous Close:
$1.47
Open:
$1.45
24h Volume:
73,065
Market Cap:
$43.92M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-1.1563
EPS:
-1.28
Net Cash Flow:
$-30.96M
1W Performance:
+27.59%
1M Performance:
-2.31%
6M Performance:
+2.07%
1Y Performance:
-54.60%
1D Range:
$1.45
$1.51
52W Range:
$0.68
$4.58
DarioHealth Corp Stock (DRIO) Company Profile
Name
DarioHealth Corp
Sector
Industry
Phone
972 4 770 4055
Address
8 HaToKhen Street, Caesarea Industrial Park, Caesarea
DarioHealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
DarioHealth Corp Stock (DRIO) Latest News
DarioHealth Corp Stock (DRIO) Financials Data
DarioHealth Corp (DRIO) Revenue 2024
DRIO reported a revenue (TTM) of $20.35 million for the quarter ending December 31, 2023, a -26.41% decline year-over-year.
DarioHealth Corp (DRIO) Net Income 2024
DRIO net income (TTM) was -$59.43 million for the quarter ending December 31, 2023, a +4.44% increase year-over-year.
DarioHealth Corp (DRIO) Cash Flow 2024
DRIO recorded a free cash flow (TTM) of -$30.96 million for the quarter ending December 31, 2023, a +36.05% increase year-over-year.
DarioHealth Corp (DRIO) Earnings per Share 2024
DRIO earnings per share (TTM) was -$1.03 for the quarter ending December 31, 2023, a +11.21% growth year-over-year.
About DarioHealth Corp
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications, and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy and distributors; and through e-stores. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.
0.03%
Cap:
|
Volume (24h):